Bridging therapy response and type as determinants of cilta-cel outcomes in relapsed/refractory multiple myeloma

Authors:
Open Access
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • National Cancer Institute (R01CA281756-01A1)
  • Pentecost Family Myeloma Research Center